Reproductive toxicology (Elmsford, N.Y.) · 2025
Association of urinary phthalate metabolites and polycystic ovary syndrome in women undergoing in vitro fertilization.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhou Wenjie, Lei Shuifang, Lv Hong, Jiang Yangqian, Sun Tianyu, Zhang Yanjie, Ma Hongxia, Wu Jie, Lin Yuan
Аннотация
BACKGROUND/OBJECTIVES: Phthalates are a group of ubiquitous environmental endocrine disruptors that can be detected in human body and exert adverse effects on reproductive health. We aimed to explore the correlation of phthalate exposure with polycystic ovary syndrome (PCOS).
METHODS: We included 420 females who underwent assisted reproductive technology (ART) treatments between 2015 and 2018 in Jiangsu, China, comprising 94 PCOS cases and 326 controls. Seventeen phthalate metabolites and three metabolites of phthalate substitutes were measured in the urine before the ART treatment. Multiple logistic and linear regression models were performed to assess the relationships of phthalate exposure with PCOS and sex hormone levels, including luteinizing hormone (LH), estradiol (E2), follicle-stimulating hormone (FSH), and mediation analysis was conducted to assess the mediating effect of sex hormones. Potential covariates in the regression models include age, area of residence, household income, education, body mass index (BMI), tobacco use and alcohol intake.
RESULTS: We found that the concentration of di (2-ethylhexyl) phthalate (ΣDEHP) (aOR = 1.40, 95 % CI: 1.02-1.92, P = 0.039) was associated with higher odds of PCOS. Additionally, increased levels of ΣDEHP (β = 0.08, 95 % CI: 0.01-0.15, P = 0.021) and its metabolites were correlated with elevated LH concentrations. In the mediation analysis, elevated LH mediated 34.56 % of the association between ΣDEHP and PCOS, respectively.
CONCLUSION: Exposure to environmental levels of DEHP was associated with increased odds of PCOS, partially mediated by elevated LH levels.
METHODS: We included 420 females who underwent assisted reproductive technology (ART) treatments between 2015 and 2018 in Jiangsu, China, comprising 94 PCOS cases and 326 controls. Seventeen phthalate metabolites and three metabolites of phthalate substitutes were measured in the urine before the ART treatment. Multiple logistic and linear regression models were performed to assess the relationships of phthalate exposure with PCOS and sex hormone levels, including luteinizing hormone (LH), estradiol (E2), follicle-stimulating hormone (FSH), and mediation analysis was conducted to assess the mediating effect of sex hormones. Potential covariates in the regression models include age, area of residence, household income, education, body mass index (BMI), tobacco use and alcohol intake.
RESULTS: We found that the concentration of di (2-ethylhexyl) phthalate (ΣDEHP) (aOR = 1.40, 95 % CI: 1.02-1.92, P = 0.039) was associated with higher odds of PCOS. Additionally, increased levels of ΣDEHP (β = 0.08, 95 % CI: 0.01-0.15, P = 0.021) and its metabolites were correlated with elevated LH concentrations. In the mediation analysis, elevated LH mediated 34.56 % of the association between ΣDEHP and PCOS, respectively.
CONCLUSION: Exposure to environmental levels of DEHP was associated with increased odds of PCOS, partially mediated by elevated LH levels.